What is SANUWAVE Health, Inc.'s 2028?

SANUWAVE Health, Inc. (SNWV) reported 2028 of $6.41M in Q1 2026.

SANUWAVE Health, Inc. SNWV 2028

2028 at other companies

IAR

Integra LifeSciencesIART

——

SolventumSOLV

——

UFP TechnologiesUFPT

——

Other financials

Income statement

See full

Revenue$9.6M+3.1%

Gross profit$7.4M+0.8%

Operating income-$1.1M-287%

Net income-$1.4M+76.5%

EPS (diluted)-$0.17+76.4%

Balance sheet

See full

Cash & equivalents$10.8M+26.8%

Total debt$21.7M+5,319%

Total equity$1.8M+109%

Total assets$37.1M+20.2%

Cash flow

See full

Operating cash flow$397.0K+126%

CapEx$23.0K-85.8%

Free cash flow$374.0K+122%

Valuation

See full

Market cap$85.99M+10.0%

Enterprise value$96.88M—

P/E5.2×—

P/S1.9×—

Profitability

See full

Gross margin76.7%+0.1pp

Operating margin7.3%-8.6pp

Net margin37.2%+21.6pp

FCF margin9%—

Returns & leverage

See full

Return on equity-173.8%—

Debt / equity11.8×—

Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s 2028?: SANUWAVE Health, Inc. (SNWV) reported 2028 of $6.41M in Q1 2026.